FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034603533> ?p ?o ?g. }

• W2034603533 abstract "To evaluate whether the addition of bevacizumab (BVZ) to capecitabine-based chemoradiotherapy in the preoperative treatment of locally advanced rectal cancer (LARC) improves efficacy measured by the pathological complete response (pCR) rate. A phase II two-step design was performed. Patients received four cycles of therapy consisting of: BVZ 10 mg/kg in first infusion on day 1 and 5 mg/kg on days 15, 29, 43, capecitabine 1800 mg/m2/day 5 days per week during radiotherapy, which consisted of external-beam irradiation (45 Gy in 1.8 Gy dose per session over 5 sessions/week for 5 weeks). Six to eight weeks after completion of all therapies surgery was undergone. To profile the biological behaviour during BVZ treatment we measured molecular biomarkers before treatment, during BVZ monotherapy, and during and after combination therapy. Microvessel density (MVD) was measured after surgery. Forty-three patients were assessed and 41 were included in the study. Three patients achieved a pathological complete response (3/40: 7.5%) and 27 (67.5%) had a pathological partial response, (overall pathological response rate of 75%). A further 8 patients (20%) had stable disease, giving a disease control rate of 95%. Downstaging occurred in 31 (31/40: 77.5%) of the patients evaluated. This treatment resulted in an actuarial 4-year disease-free and overall survival of 85.4 and 92.7% respectively. BVZ with chemoradiotherapy showed acceptable toxicity. No correlations were observed between biomarker results and efficacy variables. BVZ with capecitabine and radiotherapy seem safe and active and produce promising survival results in LARC. ClinicalTrials.gov Identifier NCT00847119 . Trial registration date: February 18, 2009." @default.
• W2034603533 created "2016-06-24" @default.
• W2034603533 creator A5000737575 @default.
• W2034603533 creator A5015194530 @default.
• W2034603533 creator A5021483506 @default.
• W2034603533 creator A5030933228 @default.
• W2034603533 creator A5033197500 @default.
• W2034603533 creator A5035175323 @default.
• W2034603533 creator A5041712131 @default.
• W2034603533 creator A5045627245 @default.
• W2034603533 creator A5046752490 @default.
• W2034603533 creator A5051615037 @default.
• W2034603533 creator A5060569859 @default.
• W2034603533 creator A5067673097 @default.
• W2034603533 creator A5068072371 @default.
• W2034603533 creator A5078401635 @default.
• W2034603533 creator A5083097777 @default.
• W2034603533 creator A5084196309 @default.
• W2034603533 date "2015-02-26" @default.
• W2034603533 modified "2023-10-17" @default.
• W2034603533 title "Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer" @default.
• W2034603533 cites W1896630734 @default.
• W2034603533 cites W1982508445 @default.
• W2034603533 cites W1984350126 @default.
• W2034603533 cites W1994615279 @default.
• W2034603533 cites W2029409133 @default.
• W2034603533 cites W2049743143 @default.
• W2034603533 cites W2078782778 @default.
• W2034603533 cites W2083716454 @default.
• W2034603533 cites W2102220427 @default.
• W2034603533 cites W2104717618 @default.
• W2034603533 cites W2107371365 @default.
• W2034603533 cites W2108051921 @default.
• W2034603533 cites W2108089475 @default.
• W2034603533 cites W2115421613 @default.
• W2034603533 cites W2115852392 @default.
• W2034603533 cites W2117713501 @default.
• W2034603533 cites W2123712900 @default.
• W2034603533 cites W2125452425 @default.
• W2034603533 cites W2130982817 @default.
• W2034603533 cites W2140183817 @default.
• W2034603533 cites W2142167347 @default.
• W2034603533 cites W2143655828 @default.
• W2034603533 cites W2144717403 @default.
• W2034603533 cites W2160776895 @default.
• W2034603533 cites W2163232628 @default.
• W2034603533 cites W48622785 @default.
• W2034603533 doi "https://doi.org/10.1186/s12885-015-1052-0" @default.
• W2034603533 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4342871" @default.
• W2034603533 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25886275" @default.
• W2034603533 hasPublicationYear "2015" @default.
• W2034603533 type Work @default.
• W2034603533 sameAs 2034603533 @default.
• W2034603533 citedByCount "21" @default.
• W2034603533 countsByYear W20346035332015 @default.
• W2034603533 countsByYear W20346035332016 @default.
• W2034603533 countsByYear W20346035332017 @default.
• W2034603533 countsByYear W20346035332018 @default.
• W2034603533 countsByYear W20346035332019 @default.
• W2034603533 countsByYear W20346035332020 @default.
• W2034603533 countsByYear W20346035332021 @default.
• W2034603533 countsByYear W20346035332022 @default.
• W2034603533 crossrefType "journal-article" @default.
• W2034603533 hasAuthorship W2034603533A5000737575 @default.
• W2034603533 hasAuthorship W2034603533A5015194530 @default.
• W2034603533 hasAuthorship W2034603533A5021483506 @default.
• W2034603533 hasAuthorship W2034603533A5030933228 @default.
• W2034603533 hasAuthorship W2034603533A5033197500 @default.
• W2034603533 hasAuthorship W2034603533A5035175323 @default.
• W2034603533 hasAuthorship W2034603533A5041712131 @default.
• W2034603533 hasAuthorship W2034603533A5045627245 @default.
• W2034603533 hasAuthorship W2034603533A5046752490 @default.
• W2034603533 hasAuthorship W2034603533A5051615037 @default.
• W2034603533 hasAuthorship W2034603533A5060569859 @default.
• W2034603533 hasAuthorship W2034603533A5067673097 @default.
• W2034603533 hasAuthorship W2034603533A5068072371 @default.
• W2034603533 hasAuthorship W2034603533A5078401635 @default.
• W2034603533 hasAuthorship W2034603533A5083097777 @default.
• W2034603533 hasAuthorship W2034603533A5084196309 @default.
• W2034603533 hasBestOaLocation W20346035331 @default.
• W2034603533 hasConcept C121608353 @default.
• W2034603533 hasConcept C126322002 @default.
• W2034603533 hasConcept C141071460 @default.
• W2034603533 hasConcept C143998085 @default.
• W2034603533 hasConcept C207886595 @default.
• W2034603533 hasConcept C2776694085 @default.
• W2034603533 hasConcept C2777802072 @default.
• W2034603533 hasConcept C2777909004 @default.
• W2034603533 hasConcept C2778424827 @default.
• W2034603533 hasConcept C2780140570 @default.
• W2034603533 hasConcept C509974204 @default.
• W2034603533 hasConcept C526805850 @default.
• W2034603533 hasConcept C71924100 @default.
• W2034603533 hasConceptScore W2034603533C121608353 @default.
• W2034603533 hasConceptScore W2034603533C126322002 @default.
• W2034603533 hasConceptScore W2034603533C141071460 @default.
• W2034603533 hasConceptScore W2034603533C143998085 @default.
• W2034603533 hasConceptScore W2034603533C207886595 @default.
• W2034603533 hasConceptScore W2034603533C2776694085 @default.
• W2034603533 hasConceptScore W2034603533C2777802072 @default.

• next